Industry Research Reports

Home > Reports > Medical Devices & Consumables > Global and United States Drug Eluting Coronary Stent System Market Report & Forecast 2024-2030

Global and United States Drug Eluting Coronary Stent System Market Report & Forecast 2024-2030

Industry: Medical Devices & Consumables

Published: 2024-11-22

Pages: 125 Pages

Report ld: 3383457

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

The global Drug Eluting Coronary Stent System revenue was US$ 5690 million in 2023 and is forecast to a readjusted size of US$ 7655 million by 2030 with a CAGR of 4.3% during the review period (2024-2030).

In United States the Drug Eluting Coronary Stent System revenue is expected to grow from US$ million in 2023 to US$ million by 2030, at a CAGR of % during the forecast period (2024-2030).

Drug Eluting Coronary Stent System Market Size

M= millions and B=billions

This report focuses on global and United States Drug Eluting Coronary Stent System market, also covers the segmentation data of other regions in regional level and county level.

The drug-eluting coronary stent system is a medical device used to treat coronary artery disease. It slowly releases drugs by coating the stent surface with a drug coating to inhibit intimal hyperplasia and reduce the occurrence of restenosis. Compared with bare metal stents, drug-eluting coronary stents have lower restenosis rates and better long-term effects.

The global key players of Drug Eluting Coronary Stent System include Boston Scientific, Medtronic, Abbott, B.Braun, BD, Biotronik AG, Stentys SA, Sino Medical, Beijing ESSEN Technology, Beijing Advanced Medical Technologies, etc. The global five biggest players hold a share of % in 2023.

Drug Eluting Coronary Stent System market is segmented in regional and country level, by players, by Type, and by Application. Companies, stakeholders, and other participants in the global Drug Eluting Coronary Stent System market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2019-2030.

For United States market, this report focuses on the Drug Eluting Coronary Stent System market size by players, by Type, and by Application, for the period 2019-2030. The key players include the global and local players which play important roles in United States.

Market Segmentation

Report Metric
Details
Report Title
Global and United States Drug Eluting Coronary Stent System Market Report & Forecast 2024-2030
Forecasted Market Size in 2030
US$ 7655 million
CAGR(2024-2030)
4.3%
Market Size Available for Years
2019-2030
Global Drug Eluting Coronary Stent System Companies Covered
Boston Scientific, Medtronic, Abbott, B.Braun, BD, Biotronik AG, Stentys SA, Sino Medical, Beijing ESSEN Technology, Beijing Advanced Medical Technologies, LifeTech Scientific Corporation, MicroPort Scientific Corporation, Yilson Medical Technology, Lepu Medical Technology, Shandong Hua'an Biotechnology
Global Drug Eluting Coronary Stent System Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Drug Eluting Coronary Stent System Market, Segment by Type
Rapamycin Eluting Stent

Everolimus Eluting Stent

Others
Global Drug Eluting Coronary Stent System Market, Segment by Application
Hospitals

Clinic

Others
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces Drug Eluting Coronary Stent System definition, global sales (volume and revenue), United States market size, United States percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Provides the analysis of various market segments by Type, covering the volume, price, revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by Application, covering the revenue, price, volume, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Detailed analysis of Drug Eluting Coronary Stent System companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Revenue and volume of Drug Eluting Coronary Stent System in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 6: Americas by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: EMEA by Type, by Application and by region, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: APAC (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Drug Eluting Coronary Stent System sales, revenue, gross margin, and recent development, etc.
Chapter 11: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 12: research findings and conclusion

Table of Contents

 1 Study Coverage
    1.1 Drug Eluting Coronary Stent System Product Introduction
    1.2 Global Drug Eluting Coronary Stent System Outlook 2019 VS 2023 VS 2030
        1.2.1 Global Drug Eluting Coronary Stent System Sales in US$ Million for the Year 2019-2030
        1.2.2 Global Drug Eluting Coronary Stent System Sales in Volume for the Year 2019-2030
    1.3 United States Drug Eluting Coronary Stent System Outlook 2019 VS 2023 VS 2030
        1.3.1 United States Drug Eluting Coronary Stent System Sales in US$ Million for the Year 2019-2030
        1.3.2 United States Drug Eluting Coronary Stent System Sales in Volume for the Year 2019-2030
    1.4 Drug Eluting Coronary Stent System Market Size, United States VS Global, 2019 VS 2023 VS 2030
        1.4.1 The Market Share of United States Drug Eluting Coronary Stent System in Global, 2019 VS 2023 VS 2030
        1.4.2 The Growth Rate of Drug Eluting Coronary Stent System Market Size, United States VS Global, 2019 VS 2023 VS 2030
    1.5 Drug Eluting Coronary Stent System Market Dynamics
        1.5.1 Drug Eluting Coronary Stent System Industry Trends
        1.5.2 Drug Eluting Coronary Stent System Market Drivers
        1.5.3 Drug Eluting Coronary Stent System Market Challenges
        1.5.4 Drug Eluting Coronary Stent System Market Restraints
    1.6 Assumptions and Limitations
    1.7 Study Objectives
    1.8 Years Considered

 2 Drug Eluting Coronary Stent System by Type
    2.1 Drug Eluting Coronary Stent System Market by Type
        2.1.1 Rapamycin Eluting Stent
        2.1.2 Everolimus Eluting Stent
        2.1.3 Others
    2.2 Global Drug Eluting Coronary Stent System Market Size by Type
        2.2.1 Global Drug Eluting Coronary Stent System Sales in Value, by Type (2019, 2023 & 2030)
        2.2.2 Global Drug Eluting Coronary Stent System Sales in Volume, by Type (2019, 2023 & 2030)
        2.2.3 Global Drug Eluting Coronary Stent System Average Selling Price (ASP) by Type (2019, 2023 & 2030)
    2.3 United States Drug Eluting Coronary Stent System Market Size by Type
        2.3.1 United States Drug Eluting Coronary Stent System Sales in Value, by Type (2019, 2023 & 2030)
        2.3.2 United States Drug Eluting Coronary Stent System Sales in Volume, by Type (2019, 2023 & 2030)
        2.3.3 United States Drug Eluting Coronary Stent System Average Selling Price (ASP) by Type (2019, 2023 & 2030)

 3 Drug Eluting Coronary Stent System by Application
    3.1 Drug Eluting Coronary Stent System Market by Application
        3.1.1 Hospitals
        3.1.2 Clinic
        3.1.3 Others
    3.2 Global Drug Eluting Coronary Stent System Market Size by Application
        3.2.1 Global Drug Eluting Coronary Stent System Sales in Value, by Application (2019, 2023 & 2030)
        3.2.2 Global Drug Eluting Coronary Stent System Sales in Volume, by Application (2019, 2023 & 2030)
        3.2.3 Global Drug Eluting Coronary Stent System Average Selling Price (ASP) by Application (2019, 2023 & 2030)
    3.3 United States Drug Eluting Coronary Stent System Market Size by Application
        3.3.1 United States Drug Eluting Coronary Stent System Sales in Value, by Application (2019, 2023 & 2030)
        3.3.2 United States Drug Eluting Coronary Stent System Sales in Volume, by Application (2019, 2023 & 2030)
        3.3.3 United States Drug Eluting Coronary Stent System Average Selling Price (ASP) by Application (2019, 2023 & 2030)

 4 Global Drug Eluting Coronary Stent System Competitor Landscape by Company
    4.1 Global Drug Eluting Coronary Stent System Market Size by Company
        4.1.1 Global Key Manufacturers of Drug Eluting Coronary Stent System, Ranked by Revenue (2023)
        4.1.2 Global Drug Eluting Coronary Stent System Revenue by Manufacturer (2019-2024)
        4.1.3 Global Drug Eluting Coronary Stent System Sales by Manufacturer (2019-2024)
        4.1.4 Global Drug Eluting Coronary Stent System Price by Manufacturer (2019-2024)
    4.2 Global Drug Eluting Coronary Stent System Concentration Ratio (CR)
        4.2.1 Drug Eluting Coronary Stent System Market Concentration Ratio (CR) (2019-2024)
        4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Drug Eluting Coronary Stent System in 2023
        4.2.3 Global Drug Eluting Coronary Stent System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Key Manufacturers of Drug Eluting Coronary Stent System, Manufacturing Base Distribution and Headquarters
    4.4 Global Key Manufacturers of Drug Eluting Coronary Stent System, Product Offered and Application
    4.5 Global Key Manufacturers of Drug Eluting Coronary Stent System, Date of Enter into This Industry
    4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
    4.7 United States Drug Eluting Coronary Stent System Market Size by Company
        4.7.1 Key Players of Drug Eluting Coronary Stent System in United States, Ranked by Revenue (2023)
        4.7.2 United States Drug Eluting Coronary Stent System Revenue by Players (2019-2024)
        4.7.3 United States Drug Eluting Coronary Stent System Sales by Players (2019-2024)

 5 Global Drug Eluting Coronary Stent System Market Size by Region
    5.1 Global Drug Eluting Coronary Stent System Market Size by Region: 2019 VS 2023 VS 2030
    5.2 Global Drug Eluting Coronary Stent System Market Size in Volume by Region (2019-2030)
        5.2.1 Global Drug Eluting Coronary Stent System Sales in Volume by Region: 2019-2024
        5.2.2 Global Drug Eluting Coronary Stent System Sales in Volume Forecast by Region (2025-2030)
    5.3 Global Drug Eluting Coronary Stent System Market Size in Value by Region (2019-2030)
        5.3.1 Global Drug Eluting Coronary Stent System Sales in Value by Region: 2019-2024
        5.3.2 Global Drug Eluting Coronary Stent System Sales in Value by Region: 2025-2030

 6 Americas
    6.1 Americas Drug Eluting Coronary Stent System Market Size YoY Growth 2019-2030
    6.2 Americas Drug Eluting Coronary Stent System Sales in Volume, by Type (2019, 2023 & 2030)
    6.3 Americas Drug Eluting Coronary Stent System Sales in Volume, by Application (2019, 2023 & 2030)
    6.4 Americas Drug Eluting Coronary Stent System Market Facts & Figures by Country (2019, 2023 & 2030)
        6.4.1 Americas Drug Eluting Coronary Stent System Sales in Value by Country (2019, 2023 & 2030)
        6.4.2 Americas Drug Eluting Coronary Stent System Sales in Volume by Country (2019, 2023 & 2030)
        6.4.3 United States
        6.4.4 Canada
        6.4.5 Mexico
        6.4.6 Brazil

 7 EMEA
    7.1 EMEA Drug Eluting Coronary Stent System Market Size YoY Growth 2019-2030
    7.2 EMEA Drug Eluting Coronary Stent System Sales in Volume, by Type (2019, 2023 & 2030)
    7.3 EMEA Drug Eluting Coronary Stent System Sales in Volume, by Application (2019, 2023 & 2030)
    7.4 EMEA Drug Eluting Coronary Stent System Market Facts & Figures by Country (2019, 2023 & 2030)
        7.4.1 EMEA Drug Eluting Coronary Stent System Sales in Value by Country (2019, 2023 & 2030)
        7.4.2 EMEA Drug Eluting Coronary Stent System Sales in Volume by Country (2019, 2023 & 2030)
        7.4.3 Europe
        7.4.4 Middle East
        7.4.5 Africa

 8 China
    8.1 China Drug Eluting Coronary Stent System Market Size YoY Growth 2019-2030
    8.2 China Drug Eluting Coronary Stent System Sales in Volume, by Type (2019, 2023 & 2030)
    8.3 China Drug Eluting Coronary Stent System Sales in Volume, by Application (2019, 2023 & 2030)

 9 APAC
    9.1 APAC Drug Eluting Coronary Stent System Market Size YoY Growth 2019-2030
    9.2 APAC Drug Eluting Coronary Stent System Sales in Volume, by Type (2019, 2023 & 2030)
    9.3 APAC Drug Eluting Coronary Stent System Sales in Volume, by Application (2019, 2023 & 2030)
    9.4 APAC Drug Eluting Coronary Stent System Market Facts & Figures by Country (2019, 2023 & 2030)
        9.4.1 APAC Drug Eluting Coronary Stent System Sales in Value by Country (2019, 2023 & 2030)
        9.4.2 APAC Drug Eluting Coronary Stent System Sales in Volume by Country (2019, 2023 & 2030)
        9.4.3 Japan
        9.4.4 South Korea
        9.4.5 China Taiwan
        9.4.6 Southeast Asia
        9.4.7 India

 10 Company Profiles
    10.1 Boston Scientific
        10.1.1 Boston Scientific Company Information
        10.1.2 Boston Scientific Description and Business Overview
        10.1.3 Boston Scientific Drug Eluting Coronary Stent System Sales, Revenue and Gross Margin (2019-2024)
        10.1.4 Boston Scientific Drug Eluting Coronary Stent System Products Offered
        10.1.5 Boston Scientific Recent Development
    10.2 Medtronic
        10.2.1 Medtronic Company Information
        10.2.2 Medtronic Description and Business Overview
        10.2.3 Medtronic Drug Eluting Coronary Stent System Sales, Revenue and Gross Margin (2019-2024)
        10.2.4 Medtronic Drug Eluting Coronary Stent System Products Offered
        10.2.5 Medtronic Recent Development
    10.3 Abbott
        10.3.1 Abbott Company Information
        10.3.2 Abbott Description and Business Overview
        10.3.3 Abbott Drug Eluting Coronary Stent System Sales, Revenue and Gross Margin (2019-2024)
        10.3.4 Abbott Drug Eluting Coronary Stent System Products Offered
        10.3.5 Abbott Recent Development
    10.4 B.Braun
        10.4.1 B.Braun Company Information
        10.4.2 B.Braun Description and Business Overview
        10.4.3 B.Braun Drug Eluting Coronary Stent System Sales, Revenue and Gross Margin (2019-2024)
        10.4.4 B.Braun Drug Eluting Coronary Stent System Products Offered
        10.4.5 B.Braun Recent Development
    10.5 BD
        10.5.1 BD Company Information
        10.5.2 BD Description and Business Overview
        10.5.3 BD Drug Eluting Coronary Stent System Sales, Revenue and Gross Margin (2019-2024)
        10.5.4 BD Drug Eluting Coronary Stent System Products Offered
        10.5.5 BD Recent Development
    10.6 Biotronik AG
        10.6.1 Biotronik AG Company Information
        10.6.2 Biotronik AG Description and Business Overview
        10.6.3 Biotronik AG Drug Eluting Coronary Stent System Sales, Revenue and Gross Margin (2019-2024)
        10.6.4 Biotronik AG Drug Eluting Coronary Stent System Products Offered
        10.6.5 Biotronik AG Recent Development
    10.7 Stentys SA
        10.7.1 Stentys SA Company Information
        10.7.2 Stentys SA Description and Business Overview
        10.7.3 Stentys SA Drug Eluting Coronary Stent System Sales, Revenue and Gross Margin (2019-2024)
        10.7.4 Stentys SA Drug Eluting Coronary Stent System Products Offered
        10.7.5 Stentys SA Recent Development
    10.8 Sino Medical
        10.8.1 Sino Medical Company Information
        10.8.2 Sino Medical Description and Business Overview
        10.8.3 Sino Medical Drug Eluting Coronary Stent System Sales, Revenue and Gross Margin (2019-2024)
        10.8.4 Sino Medical Drug Eluting Coronary Stent System Products Offered
        10.8.5 Sino Medical Recent Development
    10.9 Beijing ESSEN Technology
        10.9.1 Beijing ESSEN Technology Company Information
        10.9.2 Beijing ESSEN Technology Description and Business Overview
        10.9.3 Beijing ESSEN Technology Drug Eluting Coronary Stent System Sales, Revenue and Gross Margin (2019-2024)
        10.9.4 Beijing ESSEN Technology Drug Eluting Coronary Stent System Products Offered
        10.9.5 Beijing ESSEN Technology Recent Development
    10.10 Beijing Advanced Medical Technologies
        10.10.1 Beijing Advanced Medical Technologies Company Information
        10.10.2 Beijing Advanced Medical Technologies Description and Business Overview
        10.10.3 Beijing Advanced Medical Technologies Drug Eluting Coronary Stent System Sales, Revenue and Gross Margin (2019-2024)
        10.10.4 Beijing Advanced Medical Technologies Drug Eluting Coronary Stent System Products Offered
        10.10.5 Beijing Advanced Medical Technologies Recent Development
    10.11 LifeTech Scientific Corporation
        10.11.1 LifeTech Scientific Corporation Company Information
        10.11.2 LifeTech Scientific Corporation Description and Business Overview
        10.11.3 LifeTech Scientific Corporation Drug Eluting Coronary Stent System Sales, Revenue and Gross Margin (2019-2024)
        10.11.4 LifeTech Scientific Corporation Drug Eluting Coronary Stent System Products Offered
        10.11.5 LifeTech Scientific Corporation Recent Development
    10.12 MicroPort Scientific Corporation
        10.12.1 MicroPort Scientific Corporation Company Information
        10.12.2 MicroPort Scientific Corporation Description and Business Overview
        10.12.3 MicroPort Scientific Corporation Drug Eluting Coronary Stent System Sales, Revenue and Gross Margin (2019-2024)
        10.12.4 MicroPort Scientific Corporation Drug Eluting Coronary Stent System Products Offered
        10.12.5 MicroPort Scientific Corporation Recent Development
    10.13 Yilson Medical Technology
        10.13.1 Yilson Medical Technology Company Information
        10.13.2 Yilson Medical Technology Description and Business Overview
        10.13.3 Yilson Medical Technology Drug Eluting Coronary Stent System Sales, Revenue and Gross Margin (2019-2024)
        10.13.4 Yilson Medical Technology Drug Eluting Coronary Stent System Products Offered
        10.13.5 Yilson Medical Technology Recent Development
    10.14 Lepu Medical Technology
        10.14.1 Lepu Medical Technology Company Information
        10.14.2 Lepu Medical Technology Description and Business Overview
        10.14.3 Lepu Medical Technology Drug Eluting Coronary Stent System Sales, Revenue and Gross Margin (2019-2024)
        10.14.4 Lepu Medical Technology Drug Eluting Coronary Stent System Products Offered
        10.14.5 Lepu Medical Technology Recent Development
    10.15 Shandong Hua'an Biotechnology
        10.15.1 Shandong Hua'an Biotechnology Company Information
        10.15.2 Shandong Hua'an Biotechnology Description and Business Overview
        10.15.3 Shandong Hua'an Biotechnology Drug Eluting Coronary Stent System Sales, Revenue and Gross Margin (2019-2024)
        10.15.4 Shandong Hua'an Biotechnology Drug Eluting Coronary Stent System Products Offered
        10.15.5 Shandong Hua'an Biotechnology Recent Development

 11 Industry Chain and Sales Channels Analysis
    11.1 Drug Eluting Coronary Stent System Industry Chain Analysis
    11.2 Drug Eluting Coronary Stent System Key Raw Materials
        11.2.1 Key Raw Materials
        11.2.2 Raw Materials Key Suppliers
    11.3 Drug Eluting Coronary Stent System Production Mode & Process
    11.4 Drug Eluting Coronary Stent System Sales and Marketing
        11.4.1 Drug Eluting Coronary Stent System Sales Channels
        11.4.2 Drug Eluting Coronary Stent System Distributors
    11.5 Drug Eluting Coronary Stent System Customers

 12 Research Findings and Conclusion

 13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
            13.1.1.1 Research Programs/Design
            13.1.1.2 Market Size Estimation
            13.1.1.3 Market Breakdown and Data Triangulation
        13.1.2 Data Source
            13.1.2.1 Secondary Sources
            13.1.2.2 Primary Sources
    13.2 Author Details
    13.3 Disclaimer

Table of Figures

List of Tables
 Table 1. Drug Eluting Coronary Stent System CAGR in Value, United States VS Global, 2019 VS 2023 VS 2030
 Table 2. Drug Eluting Coronary Stent System Market Trends
 Table 3. Drug Eluting Coronary Stent System Market Drivers
 Table 4. Drug Eluting Coronary Stent System Market Challenges
 Table 5. Drug Eluting Coronary Stent System Market Restraints
 Table 6. Global Drug Eluting Coronary Stent System Sales Growth Rate (CAGR) by Type: 2019 VS 2023 VS 2030 (US$ Million)
 Table 7. United States Drug Eluting Coronary Stent System Sales Growth Rate (CAGR) by Type: 2019 VS 2023 VS 2030 (US$ Million)
 Table 8. Global Drug Eluting Coronary Stent System Sales Growth Rate (CAGR) by Application: 2019 VS 2023 VS 2030 (US$ Million)
 Table 9. United States Drug Eluting Coronary Stent System Sales Growth Rate (CAGR) by Application: 2019 VS 2023 VS 2030 (US$ Million)
 Table 10. Global Key Manufacturers of Drug Eluting Coronary Stent System, Ranked by Revenue (2023) & (US$ Million)
 Table 11. Global Drug Eluting Coronary Stent System Revenue by Manufacturer, (US$ Million) & (2019-2024)
 Table 12. Global Drug Eluting Coronary Stent System Revenue Share by Manufacturer, 2019-2024
 Table 13. Global Drug Eluting Coronary Stent System Sales by Manufacturer, (K Units), 2019-2024
 Table 14. Global Drug Eluting Coronary Stent System Sales Share by Manufacturer, 2019-2024
 Table 15. Global Drug Eluting Coronary Stent System Price by Manufacturer (2019-2024) & (US$/Unit)
 Table 16. Global Drug Eluting Coronary Stent System Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 17. Global Drug Eluting Coronary Stent System by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Eluting Coronary Stent System as of 2023)
 Table 18. Global Key Manufacturers of Drug Eluting Coronary Stent System, Manufacturing Base Distribution and Headquarters
 Table 19. Global Key Manufacturers of Drug Eluting Coronary Stent System, Product Offered and Application
 Table 20. Global Key Manufacturers of Drug Eluting Coronary Stent System, Date of Enter into This Industry
 Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 22. Key Players of Drug Eluting Coronary Stent System in United States, Ranked by Revenue (2023) & (US$ million)
 Table 23. United States Drug Eluting Coronary Stent System Revenue by Players, (US$ Million) & (2019-2024)
 Table 24. United States Drug Eluting Coronary Stent System Revenue Share by Players, (2019-2024)
 Table 25. United States Drug Eluting Coronary Stent System Sales by Players, (K Units) & (2019-2024)
 Table 26. United States Drug Eluting Coronary Stent System Sales Share by Players, (2019-2024)
 Table 27. Global Drug Eluting Coronary Stent System Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 28. Global Drug Eluting Coronary Stent System Sales in Volume by Region (2019-2024) & (K Units)
 Table 29. Global Drug Eluting Coronary Stent System Sales in Volume Forecast by Region (2025-2030) & (K Units)
 Table 30. Global Drug Eluting Coronary Stent System Sales in Value by Region (2019-2024) & (US$ Million)
 Table 31. Global Drug Eluting Coronary Stent System Sales in Value Forecast by Region (2025-2030) & (US$ Million)
 Table 32. Americas Drug Eluting Coronary Stent System Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 33. Americas Drug Eluting Coronary Stent System Sales in Value by Country (2019-2024) & (US$ Million)
 Table 34. Americas Drug Eluting Coronary Stent System Sales in Value by Country (2025-2030) & (US$ Million)
 Table 35. Americas Drug Eluting Coronary Stent System Sales in Volume by Country (2019-2024) & (K Units)
 Table 36. Americas Drug Eluting Coronary Stent System Sales in Volume by Country (2025-2030) & (K Units)
 Table 37. EMEA Drug Eluting Coronary Stent System Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 38. EMEA Drug Eluting Coronary Stent System Sales in Value by Country (2019-2024) & (US$ Million)
 Table 39. EMEA Drug Eluting Coronary Stent System Sales in Value by Country (2025-2030) & (US$ Million)
 Table 40. EMEA Drug Eluting Coronary Stent System Sales in Volume by Country (2019-2024) & (K Units)
 Table 41. EMEA Drug Eluting Coronary Stent System Sales in Volume by Country (2025-2030) & (K Units)
 Table 42. APAC Drug Eluting Coronary Stent System Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 43. APAC Drug Eluting Coronary Stent System Sales in Value by Country (2019-2024) & (US$ Million)
 Table 44. APAC Drug Eluting Coronary Stent System Sales in Value by Country (2025-2030) & (US$ Million)
 Table 45. APAC Drug Eluting Coronary Stent System Sales in Volume by Country (2019-2024) & (K Units)
 Table 46. APAC Drug Eluting Coronary Stent System Sales in Volume by Country (2025-2030) & (K Units)
 Table 47. Boston Scientific Company Information
 Table 48. Boston Scientific Description and Business Overview
 Table 49. Boston Scientific Drug Eluting Coronary Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 50. Boston Scientific Drug Eluting Coronary Stent System Product
 Table 51. Boston Scientific Recent Development
 Table 52. Medtronic Company Information
 Table 53. Medtronic Description and Business Overview
 Table 54. Medtronic Drug Eluting Coronary Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 55. Medtronic Drug Eluting Coronary Stent System Product
 Table 56. Medtronic Recent Development
 Table 57. Abbott Company Information
 Table 58. Abbott Description and Business Overview
 Table 59. Abbott Drug Eluting Coronary Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 60. Abbott Drug Eluting Coronary Stent System Product
 Table 61. Abbott Recent Development
 Table 62. B.Braun Company Information
 Table 63. B.Braun Description and Business Overview
 Table 64. B.Braun Drug Eluting Coronary Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 65. B.Braun Drug Eluting Coronary Stent System Product
 Table 66. B.Braun Recent Development
 Table 67. BD Company Information
 Table 68. BD Description and Business Overview
 Table 69. BD Drug Eluting Coronary Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 70. BD Drug Eluting Coronary Stent System Product
 Table 71. BD Recent Development
 Table 72. Biotronik AG Company Information
 Table 73. Biotronik AG Description and Business Overview
 Table 74. Biotronik AG Drug Eluting Coronary Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 75. Biotronik AG Drug Eluting Coronary Stent System Product
 Table 76. Biotronik AG Recent Development
 Table 77. Stentys SA Company Information
 Table 78. Stentys SA Description and Business Overview
 Table 79. Stentys SA Drug Eluting Coronary Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 80. Stentys SA Drug Eluting Coronary Stent System Product
 Table 81. Stentys SA Recent Development
 Table 82. Sino Medical Company Information
 Table 83. Sino Medical Description and Business Overview
 Table 84. Sino Medical Drug Eluting Coronary Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 85. Sino Medical Drug Eluting Coronary Stent System Product
 Table 86. Sino Medical Recent Development
 Table 87. Beijing ESSEN Technology Company Information
 Table 88. Beijing ESSEN Technology Description and Business Overview
 Table 89. Beijing ESSEN Technology Drug Eluting Coronary Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 90. Beijing ESSEN Technology Drug Eluting Coronary Stent System Product
 Table 91. Beijing ESSEN Technology Recent Development
 Table 92. Beijing Advanced Medical Technologies Company Information
 Table 93. Beijing Advanced Medical Technologies Description and Business Overview
 Table 94. Beijing Advanced Medical Technologies Drug Eluting Coronary Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 95. Beijing Advanced Medical Technologies Drug Eluting Coronary Stent System Product
 Table 96. Beijing Advanced Medical Technologies Recent Development
 Table 97. LifeTech Scientific Corporation Company Information
 Table 98. LifeTech Scientific Corporation Description and Business Overview
 Table 99. LifeTech Scientific Corporation Drug Eluting Coronary Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 100. LifeTech Scientific Corporation Drug Eluting Coronary Stent System Product
 Table 101. LifeTech Scientific Corporation Recent Development
 Table 102. MicroPort Scientific Corporation Company Information
 Table 103. MicroPort Scientific Corporation Description and Business Overview
 Table 104. MicroPort Scientific Corporation Drug Eluting Coronary Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 105. MicroPort Scientific Corporation Drug Eluting Coronary Stent System Product
 Table 106. MicroPort Scientific Corporation Recent Development
 Table 107. Yilson Medical Technology Company Information
 Table 108. Yilson Medical Technology Description and Business Overview
 Table 109. Yilson Medical Technology Drug Eluting Coronary Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 110. Yilson Medical Technology Drug Eluting Coronary Stent System Product
 Table 111. Yilson Medical Technology Recent Development
 Table 112. Lepu Medical Technology Company Information
 Table 113. Lepu Medical Technology Description and Business Overview
 Table 114. Lepu Medical Technology Drug Eluting Coronary Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 115. Lepu Medical Technology Drug Eluting Coronary Stent System Product
 Table 116. Lepu Medical Technology Recent Development
 Table 117. Shandong Hua'an Biotechnology Company Information
 Table 118. Shandong Hua'an Biotechnology Description and Business Overview
 Table 119. Shandong Hua'an Biotechnology Drug Eluting Coronary Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 120. Shandong Hua'an Biotechnology Drug Eluting Coronary Stent System Product
 Table 121. Shandong Hua'an Biotechnology Recent Development
 Table 122. Key Raw Materials Lists
 Table 123. Raw Materials Key Suppliers Lists
 Table 124. Drug Eluting Coronary Stent System Distributors List
 Table 125. Drug Eluting Coronary Stent System Customers List
 Table 126. Research Programs/Design for This Report
 Table 127. Key Data Information from Secondary Sources
 Table 128. Key Data Information from Primary Sources


List of Figures
 Figure 1. Drug Eluting Coronary Stent System Product Picture
 Figure 2. Global Drug Eluting Coronary Stent System Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 3. Global Drug Eluting Coronary Stent System Market Size 2019-2030 (US$ Million)
 Figure 4. Global Drug Eluting Coronary Stent System Sales 2019-2030 (K Units)
 Figure 5. United States Drug Eluting Coronary Stent System Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 6. United States Drug Eluting Coronary Stent System Market Size 2019-2030 (US$ Million)
 Figure 7. United States Drug Eluting Coronary Stent System Sales 2019-2030 (K Units)
 Figure 8. United States Drug Eluting Coronary Stent System Market Share in Global, in Value (US$ Million) 2019-2030
 Figure 9. United States Drug Eluting Coronary Stent System Market Share in Global, in Volume (K Units) 2019-2030
 Figure 10. Drug Eluting Coronary Stent System Report Years Considered
 Figure 11. Product Picture of Rapamycin Eluting Stent
 Figure 12. Product Picture of Everolimus Eluting Stent
 Figure 13. Product Picture of Others
 Figure 14. Global Drug Eluting Coronary Stent System Market Share by Type in 2023 & 2030
 Figure 15. Global Drug Eluting Coronary Stent System Sales in Value by Type (2019-2030) & (US$ Million)
 Figure 16. Global Drug Eluting Coronary Stent System Sales Market Share in Value by Type (2019-2030)
 Figure 17. Global Drug Eluting Coronary Stent System Sales by Type (2019-2030) & (K Units)
 Figure 18. Global Drug Eluting Coronary Stent System Sales Market Share in Volume by Type (2019-2030)
 Figure 19. Global Drug Eluting Coronary Stent System Price by Type (2019-2030) & (US$/Unit)
 Figure 20. United States Drug Eluting Coronary Stent System Market Share by Type in 2023 & 2030
 Figure 21. United States Drug Eluting Coronary Stent System Sales in Value by Type (2019-2030) & (US$ Million)
 Figure 22. United States Drug Eluting Coronary Stent System Sales Market Share in Value by Type (2019-2030)
 Figure 23. United States Drug Eluting Coronary Stent System Sales by Type (2019-2030) & (K Units)
 Figure 24. United States Drug Eluting Coronary Stent System Sales Market Share in Volume by Type (2019-2030)
 Figure 25. United States Drug Eluting Coronary Stent System Price by Type (2019-2030) & (US$/Unit)
 Figure 26. Product Picture of Hospitals
 Figure 27. Product Picture of Clinic
 Figure 28. Product Picture of Others
 Figure 29. Global Drug Eluting Coronary Stent System Market Share by Application in 2023 & 2030
 Figure 30. Global Drug Eluting Coronary Stent System Sales in Value by Application (2019-2030) & (US$ Million)
 Figure 31. Global Drug Eluting Coronary Stent System Sales Market Share in Value by Application (2019-2030)
 Figure 32. Global Drug Eluting Coronary Stent System Sales by Application (2019-2030) & (K Units)
 Figure 33. Global Drug Eluting Coronary Stent System Sales Market Share in Volume by Application (2019-2030)
 Figure 34. Global Drug Eluting Coronary Stent System Price by Application (2019-2030) & (US$/Unit)
 Figure 35. United States Drug Eluting Coronary Stent System Market Share by Application in 2023 & 2030
 Figure 36. United States Drug Eluting Coronary Stent System Sales in Value by Application (2019-2030) & (US$ Million)
 Figure 37. United States Drug Eluting Coronary Stent System Sales Market Share in Value by Application (2019-2030)
 Figure 38. United States Drug Eluting Coronary Stent System Sales by Application (2019-2030) & (K Units)
 Figure 39. United States Drug Eluting Coronary Stent System Sales Market Share in Volume by Application (2019-2030)
 Figure 40. United States Drug Eluting Coronary Stent System Price by Application (2019-2030) & (US$/Unit)
 Figure 41. The Top 5 and 10 Largest Manufacturers of Drug Eluting Coronary Stent System in the World: Market Share by Drug Eluting Coronary Stent System Revenue in 2023
 Figure 42. Global Drug Eluting Coronary Stent System Market Size Market Share by Region: 2019 VS 2023 VS 2030
 Figure 43. Global Drug Eluting Coronary Stent System Sales in Volume Market Share by Region (2019-2030)
 Figure 44. Global Drug Eluting Coronary Stent System Sales in Value Market Share by Region (2019-2030)
 Figure 45. Americas Drug Eluting Coronary Stent System Sales in Volume Growth Rate 2019-2030 (K Units)
 Figure 46. Americas Drug Eluting Coronary Stent System Sales in Value Growth Rate 2019-2030 (US$ Million)
 Figure 47. Americas Drug Eluting Coronary Stent System Sales by Type (2019-2030) & (K Units)
 Figure 48. Americas Drug Eluting Coronary Stent System Sales Market Share in Volume by Type (2019-2030)
 Figure 49. Americas Drug Eluting Coronary Stent System Sales by Application (2019-2030) & (K Units)
 Figure 50. Americas Drug Eluting Coronary Stent System Sales Market Share in Volume by Application (2019-2030)
 Figure 51. United States Drug Eluting Coronary Stent System Sales in Value Growth Rate (2019-2030) & (US$ Million)
 Figure 52. Canada Drug Eluting Coronary Stent System Sales in Value Growth Rate (2019-2030) & (US$ Million)
 Figure 53. Mexico Drug Eluting Coronary Stent System Sales in Value Growth Rate (2019-2030) & (US$ Million)
 Figure 54. Brazil Drug Eluting Coronary Stent System Sales in Value Growth Rate (2019-2030) & (US$ Million)
 Figure 55. EMEA Drug Eluting Coronary Stent System Sales in Volume Growth Rate 2019-2030 (K Units)
 Figure 56. EMEA Drug Eluting Coronary Stent System Sales in Value Growth Rate 2019-2030 (US$ Million)
 Figure 57. EMEA Drug Eluting Coronary Stent System Sales by Type (2019-2030) & (K Units)
 Figure 58. EMEA Drug Eluting Coronary Stent System Sales Market Share in Volume by Type (2019-2030)
 Figure 59. EMEA Drug Eluting Coronary Stent System Sales by Application (2019-2030) & (K Units)
 Figure 60. EMEA Drug Eluting Coronary Stent System Sales Market Share in Volume by Application (2019-2030)
 Figure 61. Europe Drug Eluting Coronary Stent System Sales in Value Growth Rate (2019-2030) & (US$ Million)
 Figure 62. Middle East Drug Eluting Coronary Stent System Sales in Value Growth Rate (2019-2030) & (US$ Million)
 Figure 63. Africa Drug Eluting Coronary Stent System Sales in Value Growth Rate (2019-2030) & (US$ Million)
 Figure 64. China Drug Eluting Coronary Stent System Sales in Volume Growth Rate 2019-2030 (K Units)
 Figure 65. China Drug Eluting Coronary Stent System Sales in Value Growth Rate 2019-2030 (US$ Million)
 Figure 66. China Drug Eluting Coronary Stent System Sales by Type (2019-2030) & (K Units)
 Figure 67. China Drug Eluting Coronary Stent System Sales Market Share in Volume by Type (2019-2030)
 Figure 68. China Drug Eluting Coronary Stent System Sales by Application (2019-2030) & (K Units)
 Figure 69. China Drug Eluting Coronary Stent System Sales Market Share in Volume by Application (2019-2030)
 Figure 70. APAC Drug Eluting Coronary Stent System Sales in Volume Growth Rate 2019-2030 (K Units)
 Figure 71. APAC Drug Eluting Coronary Stent System Sales in Value Growth Rate 2019-2030 (US$ Million)
 Figure 72. APAC Drug Eluting Coronary Stent System Sales by Type (2019-2030) & (K Units)
 Figure 73. APAC Drug Eluting Coronary Stent System Sales Market Share in Volume by Type (2019-2030)
 Figure 74. APAC Drug Eluting Coronary Stent System Sales by Application (2019-2030) & (K Units)
 Figure 75. APAC Drug Eluting Coronary Stent System Sales Market Share in Volume by Application (2019-2030)
 Figure 76. Japan Drug Eluting Coronary Stent System Sales in Value Growth Rate (2019-2030) & (US$ Million)
 Figure 77. South Korea Drug Eluting Coronary Stent System Sales in Value Growth Rate (2019-2030) & (US$ Million)
 Figure 78. China Taiwan Drug Eluting Coronary Stent System Sales in Value Growth Rate (2019-2030) & (US$ Million)
 Figure 79. Southeast Asia Drug Eluting Coronary Stent System Sales in Value Growth Rate (2019-2030) & (US$ Million)
 Figure 80. India Drug Eluting Coronary Stent System Sales in Value Growth Rate (2019-2030) & (US$ Million)
 Figure 81. Drug Eluting Coronary Stent System Value Chain
 Figure 82. Drug Eluting Coronary Stent System Production Process
 Figure 83. Channels of Distribution (Direct Vs Distribution)
 Figure 84. Bottom-up and Top-down Approaches for This Report
 Figure 85. Data Triangulation
 Figure 86. Key Executives Interviewed

Description

The global Drug Eluting Coronary Stent System revenue was US$ 5690 million in 2023 and is forecast to a readjusted size of US$ 7655 million by 2030 with a CAGR of 4.3% during the review period (2024-2030).

In United States the Drug Eluting Coronary Stent System revenue is expected to grow from US$ million in 2023 to US$ million by 2030, at a CAGR of % during the forecast period (2024-2030).

This report focuses on global and United States Drug Eluting Coronary Stent System market, also covers the segmentation data of other regions in regional level and county level.

Market Segmentation